(1-{5-[2-(2-fluorophenyl)ethenyl]-3-methyl-1,2-oxazole-4-sulfonyl}piperidin-4-yl)(3-methyl-3,4-dihydro-1,5-benzothiazepin-5(2H)-yl)methanone
Chemical Structure Depiction of
(1-{5-[2-(2-fluorophenyl)ethenyl]-3-methyl-1,2-oxazole-4-sulfonyl}piperidin-4-yl)(3-methyl-3,4-dihydro-1,5-benzothiazepin-5(2H)-yl)methanone
(1-{5-[2-(2-fluorophenyl)ethenyl]-3-methyl-1,2-oxazole-4-sulfonyl}piperidin-4-yl)(3-methyl-3,4-dihydro-1,5-benzothiazepin-5(2H)-yl)methanone
Compound characteristics
Compound ID: | G637-1073 |
Compound Name: | (1-{5-[2-(2-fluorophenyl)ethenyl]-3-methyl-1,2-oxazole-4-sulfonyl}piperidin-4-yl)(3-methyl-3,4-dihydro-1,5-benzothiazepin-5(2H)-yl)methanone |
Molecular Weight: | 555.69 |
Molecular Formula: | C28 H30 F N3 O4 S2 |
Smiles: | CC1CN(C(C2CCN(CC2)S(c2c(C)noc2/C=C/c2ccccc2F)(=O)=O)=O)c2ccccc2SC1 |
Stereo: | RACEMIC MIXTURE |
logP: | 5.036 |
logD: | 5.036 |
logSw: | -4.5413 |
Hydrogen bond acceptors count: | 10 |
Polar surface area: | 69.042 |
InChI Key: | BTEXLCYMAIMLJD-IBGZPJMESA-N |